RxDoctor Payments Data

Jessica Dickey

Psychiatric/Mental Health · Weirton, WVNPI 1861090904

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 40.4% of the total. Reporting peaked in 2024 at $846 and has fallen 59.7% since, to $341 in 2025.

$2,303in general payments, 2019–2025

Across 91 payments — averaging $25.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$930
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$428
  • Otsuka America Pharmaceutical, Inc.$196
  • Supernus Pharmaceuticals, Inc.$151
  • Teva Pharmaceuticals USA, Inc.$132
  • Alkermes, Inc.$125
  • plus $341 from 8 others

What the payments were for

  • Food & beverage$2,303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,303 in reported general payments places this provider in the 80th percentile of 142 psychiatric/mental health providers in West Virginia.

See all psychiatric/mental health providers in West Virginia

Medicare billing

Part B allowed, 2024
$27,037
Medicare patients
106
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rivastigmine30$5,084
Divalproex Sodium24$2,677
Duloxetine Hcl77$2,598
Mirtazapine74$1,179
Quetiapine Fumarate ErQuetiapine Fumarate31$1,003
Oxcarbazepine17$762
Buspirone Hcl67$738
Venlafaxine Hcl ErVenlafaxine Hcl20$557
Citalopram HbrCitalopram Hydrobromide78$475
Escitalopram Oxalate69$464
Aripiprazole32$361
Trazodone Hcl50$350
Quetiapine Fumarate40$302
Risperidone31$280
Memantine Hcl15$275

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Weirton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →